NAICS Code 621340-10 - Chelation Therapy

Marketing Level - NAICS 8-Digit

Business Lists and Databases Available for Marketing and Research

Total Verified Companies: 1
Contact Emails: 1
Company Websites: 1
Phone Numbers: 1
Business Addresses: 1
Companies with Email: Inquire
Get Business List
NAICS CODE 621340-10
Reach new customers, connect with decision makers, and grow your business.
Pricing from $0.05 to $0.25 per lead
Ideal for: Direct Mailing Email Campaigns Calling Market Research ‐ Free Sample & Report, Custom Lists, and Expert Support — All Included
Looking for more companies? See NAICS 621340 - Offices of Physical, Occupational and Speech Therapists, and Audiologists - 211,203 companies, 113,559 emails.

NAICS Code 621340-10 Description (8-Digit)

Chelation Therapy is a medical treatment that involves the use of chelating agents to remove heavy metals and other toxins from the body. The therapy is typically administered intravenously and is used to treat a range of conditions, including lead poisoning, atherosclerosis, and coronary artery disease. Chelation Therapy works by binding to heavy metals and other toxins in the bloodstream, which are then excreted from the body through the urine. The therapy is often used as an alternative to surgery or other invasive procedures and is generally considered safe when administered by a qualified healthcare professional.

Parent Code - Official US Census

Official 6‑digit NAICS codes serve as the parent classification used for government registrations and documentation. The marketing-level 8‑digit codes act as child extensions of these official classifications, providing refined segmentation for more precise targeting and detailed niche insights. Related industries are listed under the parent code, offering a broader context of the industry environment. For further details on the official classification for this industry, please visit the U.S. Census Bureau NAICS Code 621340 page

Tools

Tools commonly used in the Chelation Therapy industry for day-to-day tasks and operations.

  • EDTA (ethylenediaminetetraacetic acid)
  • DMPS (2,3-dimercapto-1-propanesulfonic acid)
  • DMSA (dimercaptosuccinic acid)
  • Vitamin C
  • Magnesium
  • Zinc
  • Selenium
  • Glutathione
  • Alpha-lipoic acid
  • N-acetylcysteine

Industry Examples of Chelation Therapy

Common products and services typical of NAICS Code 621340-10, illustrating the main business activities and contributions to the market.

  • Heavy metal toxicity
  • Atherosclerosis
  • Coronary artery disease
  • Autism
  • Alzheimer's disease
  • Parkinson's disease
  • Multiple sclerosis
  • Chronic fatigue syndrome
  • Fibromyalgia
  • Peripheral artery disease

History

A concise historical narrative of NAICS Code 621340-10 covering global milestones and recent developments within the United States.

  • Chelation therapy has been used for over 50 years to treat heavy metal poisoning, such as lead and mercury. In the 1950s, it was discovered that chelation therapy could also be used to treat atherosclerosis, a condition where plaque builds up in the arteries. Since then, chelation therapy has been used as an alternative treatment for heart disease, autism, and other conditions. In recent years, chelation therapy has gained popularity in the United States as a complementary and alternative medicine (CAM) treatment for heart disease. However, the effectiveness of chelation therapy for heart disease is still a topic of debate in the medical community. Recent history of chelation therapy in the United States has been marked by controversy. In 2012, the National Institutes of Health (NIH) conducted a clinical trial to determine the effectiveness of chelation therapy for heart disease. The trial, known as the Trial to Assess Chelation Therapy (TACT), found that chelation therapy was effective in reducing the risk of heart attacks, strokes, and other cardiovascular events in patients with a history of heart disease. However, the study has been criticized for its small sample size and lack of a placebo group. Despite the controversy, chelation therapy continues to be used as a CAM treatment for heart disease in the United States.